University of Miami
University of Miami
Miami, Florida, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | Fibrosis, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, graft versus host disease, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-28 | NCT05531786 | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma | Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Not applicable | 2026-06-16 | NCT05323253 |